Axogen Advances Prostate Market Launch, Citing $754 Million U.S. TAM
Axogen plans to launch a prostate-market product, targeting a $754M U.S. market. The company estimates 110,000 annual prostatectomy cases with a $7,000 per-procedure price. Axogen's COAPT technique, using Avance nerve allograft, has shown 80% of patients with better-than-expected erectile function after six months. 88% of surveyed patients expressed interest in the procedure.

